Stock EVFM EVOFEM BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Evofem Biosciences, Inc.

Equities

EVFM

US30048L3024

Market Closed - OTC Markets
Other stock markets
 03:59:37 2024-05-24 pm EDT 		5-day change 1st Jan Change
0.016 USD +14.29% Intraday chart for Evofem Biosciences, Inc. +10.34% -75.00%
May. 16 Transcript : Evofem Biosciences, Inc. - Special Call
May. 15 Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Evofem Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023
Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
MEI Pharma's Finance Chief Brian Drazba to Step Down; Company Names Justin File as Successor
MEI Pharma Names Justin File as Chief Financial Officer
Evofem Biosciences, Inc. Receives Paragraph IV Certification Notice Letter from Padagis Israel Pharmaceuticals Ltd
Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Evofem Biosciences, Inc. Auditor Raises 'Going Concern' Doubt
Evofem Biosciences, Inc. Appoints Ivy Zhang as Secretary
Evofem Biosciences, Inc. Terminates Katherine Atkinson as Chief Commercial Officer
Evofem Biosciences, Inc. Approves a Reduction in Force
Evofem Biosciences, Inc.'s Phexxi Contraceptive Gel Added to SimpleHealth Product Offering
Evofem Biosciences to Explore and Evaluate Strategic Alternatives
Evofem Biosciences, Inc. Announces Resignation of Jenny Yip as Member of Board of Director
Evofem Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Evofem Biosciences, Inc. Appoints Justin J. File as Secretary
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVFM Stock
  4. News Evofem Biosciences, Inc.
  5. Other languages